These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20190287)

  • 1. Immunologic tolerance to the insulin analogue glulisine.
    Ozaki N; Oiso Y
    Diabetes Care; 2010 Mar; 33(3):e39. PubMed ID: 20190287
    [No Abstract]   [Full Text] [Related]  

  • 2. Desensitization-resistant insulin allergy.
    Frigerio C; Aubry M; Gomez F; Graf L; Dayer E; de Kalbermatten N; Gaillard RC; Spertini F
    Allergy; 1997 Feb; 52(2):238-9. PubMed ID: 9105538
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic tolerance to intravenously injected insulin.
    Asai M; Yoshida M; Miura Y
    N Engl J Med; 2006 Jan; 354(3):307-9. PubMed ID: 16421379
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs.
    Mollar-Puchades MA; Villanueva IL
    Diabetes Res Clin Pract; 2009 Jan; 83(1):e21-2. PubMed ID: 19070911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin desensitization with insulin lispro and an insulin pump in a 5-year-old child.
    Eapen SS; Connor EL; Gern JE
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):395-7. PubMed ID: 11101184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergies to human insulin.
    Berke L; Owen JA; Atkinson RL
    Diabetes Care; 1984; 7(4):402-3. PubMed ID: 6381011
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of insulin glulisine in patients with type 1 diabetes.
    Dreyer M; Prager R; Robinson A; Busch K; Ellis G; Souhami E; Van Leendert R
    Horm Metab Res; 2005 Nov; 37(11):702-7. PubMed ID: 16308840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omalizumab for drug allergy.
    Matheu V; Franco A; Perez E; Hernández M; Barrios Y
    J Allergy Clin Immunol; 2007 Dec; 120(6):1471-2; author reply 1472-3. PubMed ID: 17854881
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperpigmentation due to insulin allergy.
    Neki NS; Gupta SN; Mani T; Gupta H
    Natl Med J India; 2014; 27(3):183. PubMed ID: 25668097
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment with human analog (GlyA21, ArgB31, ArgB32) insulin glargine (HOE901) resolves a generalized allergy to human insulin in type 1 diabetes.
    Moriyama H; Nagata M; Fujihira K; Yamada K; Chowdhury SA; Chakrabarty S; Jin Z; Yasuda H; Ueda H; Yokono K
    Diabetes Care; 2001 Feb; 24(2):411-2. PubMed ID: 11213905
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin allergy and insulin resistance.
    Goldfine AB; Kahn CR
    Curr Ther Endocrinol Metab; 1994; 5():461-4. PubMed ID: 7704774
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes.
    Garg SK; Ellis SL; Ulrich H
    Expert Opin Pharmacother; 2005 Apr; 6(4):643-51. PubMed ID: 15934890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged desensitization required for treatment of generalized allergy to human insulin.
    Thompson DM; Ronco JJ
    Diabetes Care; 1993 Jun; 16(6):957-8. PubMed ID: 8325221
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of insulin allergy in a 1-year-old infant with neonatal diabetes by lispro and glargine insulin.
    Kara C; Kutlu AO; Evliyaoglu O; Bilgili H; Yildirim N
    Diabetes Care; 2005 Apr; 28(4):983-4. PubMed ID: 15793215
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy.
    Hasselmann C; Pecquet C; Bismuth E; Raverdy C; Sola-Gazagnes A; Lobut JB; Carel JC; Tubiana-Rufi N
    Diabetes Metab; 2013 Apr; 39(2):174-7. PubMed ID: 23206896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin glulisine: a review of its use in the management of diabetes mellitus.
    Drugs; ; . PubMed ID: 19496630
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.